| 000 | 01222 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250515221751.0 | ||
| 264 | 0 | _c20100806 | |
| 008 | 201008s 0 0 eng d | ||
| 022 | _a1744-7658 | ||
| 024 | 7 |
_a10.1517/13543781003769844 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCassell, Andre | |
| 245 | 0 | 0 |
_aInvestigational EGFR-targeted therapy in head and neck squamous cell carcinoma. _h[electronic resource] |
| 260 |
_bExpert opinion on investigational drugs _cJun 2010 |
||
| 300 |
_a709-22 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xpharmacology |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 | _aDrug Delivery Systems |
| 650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aHead and Neck Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 700 | 1 | _aGrandis, Jennifer R | |
| 773 | 0 |
_tExpert opinion on investigational drugs _gvol. 19 _gno. 6 _gp. 709-22 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/13543781003769844 _zAvailable from publisher's website |
| 999 |
_c19773009 _d19773009 |
||